SARS-COV-2 IgG (COVID-19 Immune Response) – Consumer Direct Access Test

SARS-COV-2 IgG serum antibody test can help identify past or recent exposure to COVID-19 infection.

This test is well suited for the purpose of population screening, and in most cases can be directly accessed by consumers.

An IgG positive test may suggest protective immunity after resolution of primary infection with SARS-COV-2, but the relationship between IgG positivity and immunity to SARS-COV-2 has not yet been firmly established.

Experience with other viruses indicate that individuals who have IgG antibodies and are actively infected with the virus may be able to resume daily activities in society and contact restrictions can be removed.